Mersana Therapeutics Inc Asset Turnover Ratio (MRSN), as of third quarter 2025, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Mersana Therapeutics inc   (NASDAQ: MRSN)
 

Mersana Therapeutics Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Mersana Therapeutics Inc asset turnover ratio, the ability of Mersana Therapeutics Inc 's assets to generate revenue in the third quarter 2025, increased sequentially to 0.34 in the third quarter (Sep 30 2025), MRSN's balance sheet remain strong.

Within sector 110 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the Third Quarter 2025 compared to the preceding quarter from 2426 to 2506.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

MRSN Asset Turnover Ratio (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter		 (Dec 31 2024)
IV. Quarter		 (Sep 30 2024)
III. Quarter
Y / Y Asset Change -62.94 % -52.78 % -43.29 % -35.68 % -35.4 %
Y / Y Revenue Change -12.61 % 33.28 % -70.21 % 52.89 % 63.65 %
Asset Turnover Ratio (TTM) 0.34 0.28 0.23 0.24 0.19
MRSN's Total Ranking # 2506 # 2426 # 229 # 2445 # 2445
Seq. Asset Change -25.75 % -24.77 % -22.51 % -14.37 % -5.41 %
Seq. Revenue Change 260.24 % 10.97 % -83.17 % 29.87 % 449.41 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 111
Healthcare Sector # 373
Overall Market # 2506

Asset Turnover Ratio Statistics
High Average Low
0.33 0.1 -0
(Sep 30 2025)  




MRSN Company Profile • Back to MRSN Efficiency Comparisons • Compare MRSN Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Sep 30 2025, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Sep 30 2025 Assets at quarter ending Sep 30 2025
Kewaunee Scientific Corporation  1.49 $ 286.067  Millions$ 191.591  Millions
Indivior Pharmaceuticals Inc   1.49 $ 2,068.000  Millions$ 1,389.750  Millions
Koru Medical Systems Inc   1.46 $ 39.071  Millions$ 26.764  Millions
Rigel Pharmaceuticals Inc  1.43 $ 282.076  Millions$ 197.305  Millions
Avadel Pharmaceuticals Plc  1.38 $ 248.762  Millions$ 179.698  Millions
Infusystem Holdings Inc  1.38 $ 141.054  Millions$ 101.907  Millions
Viemed Healthcare Inc   1.37 $ 254.794  Millions$ 185.528  Millions
Mimedx Group Inc   1.37 $ 391.483  Millions$ 286.108  Millions
Nephros Inc   1.35 $ 16.339  Millions$ 12.120  Millions
Dynatronics Corporation  1.35 $ 26.815  Millions$ 19.914  Millions
Xtant Medical Holdings Inc   1.34 $ 133.544  Millions$ 99.868  Millions
Rockwell Medical inc   1.33 $ 74.448  Millions$ 55.820  Millions
Aveanna Healthcare Holdings Inc   1.33 $ 2,290.591  Millions$ 1,726.391  Millions
Medpace Holdings Inc   1.29 $ 2,358.373  Millions$ 1,830.730  Millions
Biocryst Pharmaceuticals Inc   1.28 $ 599.816  Millions$ 468.520  Millions
Evolus Inc   1.27 $ 284.763  Millions$ 223.433  Millions
Sanuwave Health Inc   1.27 $ 41.283  Millions$ 32.405  Millions
Ardent Health Inc   1.26 $ 6,325.549  Millions$ 5,012.246  Millions
Idexx Laboratories Inc  1.26 $ 4,166.125  Millions$ 3,306.159  Millions
Hca Healthcare Inc   1.25 $ 74,372.000  Millions$ 59,648.500  Millions
Electromed Inc   1.24 $ 65.500  Millions$ 53.025  Millions
Warby Parker Inc   1.23 $ 849.660  Millions$ 692.016  Millions
Precipio inc   1.22 $ 22.800  Millions$ 18.687  Millions
Natera Inc   1.21 $ 2,116.674  Millions$ 1,742.912  Millions
Henry Schein Inc   1.21 $ 12,938.000  Millions$ 10,675.250  Millions
Sunshine Biopharma Inc   1.21 $ 37.324  Millions$ 30.800  Millions
Zynex inc   1.21 $ 108.253  Millions$ 89.774  Millions
Healthlynked Corp  1.20 $ 2.374  Millions$ 1.973  Millions
Exagen Inc   1.20 $ 61.719  Millions$ 51.642  Millions
Elite Pharmaceuticals Inc   1.19 $ 121.713  Millions$ 102.157  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.